Bristol-Myers Squibb has selected a site in Ft. Devens, MA for a $1.1 billion manufacturing plant that will employ up to 550 people. The plant--which will fill 750,000 square feet of space--will produce the recently approved Orencia and other pharmaceuticals. The decision by BMS is a big boost for Massachusetts biotech cluster. The state's main claim to biotech fame has been in R&D. Massachusetts had to beat out North Carolina and other states' ambitious economic development groups. Ft. Devens is about 35 miles from Boston.
- here's the AP report on the new plant